Therapeutic Solutions International Inc (TSOI)

[BigBadWolf]

TSOI y PAUL btw Wonder if any of the investing public has any/all trade data relating to PAUL (institutional) era
Insiders no Form 4s filed or needed / Noteholders cashing out (as is their right) from Dixon's selling of (discounted?) paper to survive, well now sadly that's another story entirely
https://www.sec.gov/comments/s7-24-20/s72420-228879.htm

Any really wonder what’s happening to the pps. Get Real just look @ O/S y DTC. ONLY 1 person I know of??? Who can originate/sign off on those notes.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

On January 4, 2022, we issued 1,034,482 shares of common stock for $30,000 of accrued salaries.

On January 14, 2022, we issued 4,158,759 shares of common stock for the complete conversion of $56,975 for convertible note dated July 12, 2021.

On February 4, 2022, we issued 4,778,689 shares of common stock for the complete conversion of $58,300 for convertible note dated August 2, 2021.

On February 14, 2022, we issued 24,500,000 shares of common stock, valued at $0.01 per share, for an investment in the Company’s Private Placement.

On February 24, 2022, we issued 10,000,000 shares of common stock, valued at $0.01 per share, for an investment in the Company’s Private Placement.

On February 23, 2022, we issued 149,402,390 shares of common stock, valued at $0.0208 per share, for a license.

On March 31, 2022, we issued 10,000,000 shares of common stock, valued at $0.01 per share, for an investment in the Company’s Private Placement.

On April 4, 2022,we issued 6,786,585 shares of common stock for the complete conversion of $83,475 for convertible note dated October 1. 2021.

On April 5, 2022, we issued 9,000,000 shares of common stock, valued at $0.0251 per share, for consulting services.

On May 2, 2022, we issued 7,000,000 shares of common stock, valued at $0.026 per share, for consulting services.

On May 2, 2022, we issued 3,571,994 shares of common stock for the complete conversion of $56,438 for convertible note dated November 2, 2021.

On May 3, 2022, we issued 2,000,000 shares of common stock, valued at $0.0254 per share, for consulting services.

On May 4, 2022, we issued 2,000,000 shares of common stock, valued at $0.0259 per share, for consulting services.

On May 24, 2022, we issued 2,000,000 shares of common stock, valued at $0.02261 per share, for consulting services.

On June 16, 2022, we issued 2.919.708 shares of common stock for the partial conversion of $40,000 for convertible note dated December 15, 2021.

On June 17, we issued 1,951,993 shares of common stock for the complete conversion of $26,938 for convertible note dated December 15, 2021.

Item 1. Legal Proceedings

From time to time, claims are made against us in the ordinary course of business, which could result in litigation. Claims and associated litigation are subject to inherent uncertainties and unfavorable outcomes could occur, such as monetary damages, fines, penalties or injunctions prohibiting us from selling one or more products or engaging in other activities. The occurrence of an unfavorable outcome in any specific period could have a material adverse effect on our results of operations for that period or future periods.

However, as of the date of this report, management believes the outcome of currently identified potential claims and lawsuits will not have a material adverse effect on our financial condition or results of operations.

https://www.otcmarkets.com/filing/html?id=16030841&guid=o1w-kKH-nwOCJth